Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031334
Abstract: Asprosin is a newly identified adipokine with glucose-raising and appetite-enhancing effects which acts differently from the known hepatic glucose utilization pathway. This study investigated changes in serum asprosin levels in normal weight or overweight/obese liraglutide-treated… read more here.
Keywords: overweight obesity; asprosin; t2dm patients; normal weight ... See more keywords
Asprosin in pregnancy and childhood
Sign Up to like & getrecommendations! Published in 2020 at "Molecular and Cellular Pediatrics"
DOI: 10.1186/s40348-020-00110-8
Abstract: Introduction The prevalence for childhood overweight and obesity increased steadily in the past decades. Childhood obesity was defined as a disease by the World Health Organization [25] and by the American Medical Association (2013) [7]… read more here.
Keywords: overweight obese; asprosin; pregnancy; childhood ... See more keywords
Decrease in serum asprosin levels following six weeks of spinning and stationary cycling training in overweight women
Sign Up to like & getrecommendations! Published in 2022 at "Hormone Molecular Biology and Clinical Investigation"
DOI: 10.1515/hmbci-2022-0003
Abstract: Abstract Objectives Secreted by white adipose tissue, asprosin is a newly recognized adipokine whose physiological function is not well comprehended. This study intended to determine the effect of spinning and stationary cycling on serum asprosin… read more here.
Keywords: asprosin; serum asprosin; group; stationary cycling ... See more keywords